Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction

J Am Coll Cardiol. 2024 Apr 9;83(14):1348-1350. doi: 10.1016/j.jacc.2024.01.033.

Authors

Aditya Achanta¹, Lauren Belak², Christine S Ritchie², James L Januzzi², Jason H Wasfy²

Affiliations

¹ Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: aachanta@mgh.harvard.edu.
² Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

PMID: 38569765
DOI: 10.1016/j.jacc.2024.01.033

No abstract available

Publication types

Letter

MeSH terms

Glucagon-Like Peptide 1
Heart Failure* / drug therapy
Humans
Obesity / complications
Stroke Volume
Ventricular Function, Left

Substances

Glucagon-Like Peptide 1